EP
IART icon

Essential Partners’s Integra LifeSciences IART Stock Holding History

Essential Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.72K Buy
+263
New +$3.68K ﹤0.01% 1569
2026
Q1 		– Sell
-28
Closed -$348 – 2920
2025
Q4 		$348 Sell
28
-189
-87% -$2.51K ﹤0.01% 2309
2025
Q3 		$3.11K Buy
+217
New +$2.97K ﹤0.01% 1624

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Essential Partners's IART Position: Q2 2026 in Review

Essential Partners opened a new position in Integra LifeSciences (IART) in Q2 2026: 263 shares worth $4.72K. The stake represents ﹤0.01% of the portfolio and ranks #1569 among its holdings. This is a return to the name: Essential Partners previously reported a position in IART as recently as Q4 2025.

Essential Partners first reported a position in IART in Q3 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Essential Partners held 263 shares of Integra LifeSciences worth $4.72K as of Q2 2026.
  • Integra LifeSciences was a new Essential Partners position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1569 holding.
  • Essential Partners first reported a position in Integra LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.